Erythrocytes, commonly known as red blood cells, are the most abundant cell type in your blood and serve as your body’s oxygen delivery system. Each of these tiny, disc-shaped cells is packed with hemoglobin, the protein that picks up oxygen in the lungs and drops it off in tissues. But red blood cells do far more than ferry oxygen: they help transport carbon dioxide back to the lungs, contribute to blood flow regulation, and interact with immune and infectious processes in ways that are still being mapped out.
Why the Shape Matters
A healthy red blood cell looks like a flattened disc with a slight dip on both sides, a shape biologists call a biconcave disc. That shape is not decorative. It maximizes the cell’s surface area relative to its volume, which means gases like oxygen and carbon dioxide can cross the membrane faster. It also allows the cell to fold and squeeze through capillaries narrower than its own diameter without rupturing.
The ability to deform under pressure depends on a meshwork of proteins just beneath the cell membrane. Spectrin, the main scaffold protein, links together with actin and other connectors to form a flexible net. That net is anchored to the outer membrane through proteins like band 3 and protein 4.1. When those anchor connections work well, the cell stays both sturdy and pliable. Researchers have identified that out of hundreds of membrane proteins, only about 14 show a strong relationship with how deformable the cell is, and most of those are the very proteins that connect the outer membrane to the underlying skeleton.1PubMed Central. Red Blood Cell Deformability Is Expressed by a Set of Interrelated Membrane Proteins When those connections break down, the cell loses surface area and becomes rigid, which is exactly what happens in certain inherited blood disorders.
Picking Up and Dropping Off Oxygen
Hemoglobin is the workhorse protein inside every red blood cell, and each cell contains roughly 270 million copies of it. A single hemoglobin molecule can carry up to four oxygen molecules at once, and it does so with a clever trick called cooperative binding: once the first oxygen molecule attaches, the remaining binding sites open up more eagerly. This means hemoglobin loads oxygen very efficiently in the oxygen-rich environment of the lungs and then readily unloads it in tissues where oxygen levels are lower.
This switch between eager and reluctant binding reflects a physical change in the hemoglobin molecule’s shape. In the lungs, hemoglobin shifts into a “relaxed” form with high oxygen affinity. In the tissues, it settles into a “tense” form that lets oxygen go more easily.2PubMed Central. Free energy changes and components implicit in the MWC allosteric model for the cooperative oxygen binding of hemoglobin The structural interplay between hemoglobin’s subunits is asymmetric: the alpha and beta subunits play different roles, and the interactions between them are essential for the cooperative loading and unloading to work properly.3PubMed Central. Structural origin of cooperativity in human hemoglobin
Your body can also fine-tune how readily hemoglobin releases oxygen. A molecule called 2,3-BPG (bisphosphoglycerate), produced inside the red blood cell itself, binds to hemoglobin and reduces its grip on oxygen, making the cell more generous in handing oxygen over to tissues. This adjustment is part of what happens when you go to high altitude, where the air has less oxygen and the body needs to extract every bit it can from the blood.
Carbon Dioxide and Acid-Base Balance
Oxygen delivery gets most of the attention, but red blood cells handle roughly 70 percent of the carbon dioxide your tissues produce. Most of this carbon dioxide does not travel in the blood as a dissolved gas. Instead, it enters the red blood cell, where an enzyme called carbonic anhydrase rapidly converts it to bicarbonate. That bicarbonate then slips out of the cell into the plasma and rides the bloodstream to the lungs. In the lungs, the process reverses: bicarbonate re-enters the red blood cell, gets converted back into carbon dioxide, and you exhale it.4ScienceDirect. Erythrocyte mechanisms in the transport of carbon dioxide: An optional scheme
This shuttle system does double duty. By regulating bicarbonate levels, red blood cells help keep your blood pH in the narrow range your enzymes and organs need. Without this buffering function, your blood would become dangerously acidic during exercise, illness, or any other time your tissues are burning through fuel and producing carbon dioxide at a high rate.
How Red Blood Cells Are Made
Your bone marrow churns out roughly two million new red blood cells every second. The process, called erythropoiesis, starts with stem cells in the marrow that gradually commit to becoming red blood cells. Over about a week, those precursors shrink, pack themselves full of hemoglobin, and eventually eject their nucleus. That last step is unusual among human cells: by discarding the nucleus, the mature red blood cell gives up the ability to divide or make new proteins but gains more room for hemoglobin and a more flexible shape.
The signal that controls how many new red blood cells are produced comes mainly from the kidneys. When your tissues are not getting enough oxygen, whether because of blood loss, anemia, lung disease, or high altitude, cells in the kidneys sense the drop and ramp up production of the hormone erythropoietin (EPO). The oxygen-sensing mechanism behind this relies on proteins called hypoxia-inducible factors, which trigger a cascade that increases EPO production, boosts iron absorption, and adjusts the bone marrow environment to push more red cell precursors toward maturity.5PubMed Central. Regulation of erythropoiesis by hypoxia-inducible factors
Iron is the critical raw material. Each hemoglobin molecule requires four iron atoms, and your body tightly regulates how much iron enters and exits the blood. The liver produces a hormone called hepcidin that acts as a gatekeeper, controlling iron absorption from the gut and iron recycling from old red blood cells.6Haematologica. Iron metabolism and iron disorders revisited in the hepcidin era When hepcidin levels are too high, iron gets locked away and red blood cell production suffers even if there is iron stored in the body. This mismatch is part of what drives the anemia that often accompanies chronic infections or inflammatory diseases.
Living Without a Nucleus
Because mature red blood cells have no nucleus, mitochondria, or ribosomes, they cannot repair themselves, make new proteins, or burn fuel using the oxygen they carry. Instead, they depend entirely on glycolysis, the simplest energy-generating pathway, which breaks down glucose to produce ATP without requiring oxygen. That ATP powers the ion pumps that maintain the cell’s shape and internal chemistry. The red blood cell also releases some of this ATP externally when it squeezes through tiny blood vessels or encounters low-oxygen conditions, and that released ATP acts as a signal telling nearby blood vessel walls to relax, improving blood flow where it is most needed.7PubMed Central. Generation and Export of Red Blood Cell ATP in Health and Disease
Red blood cells also run a parallel pathway called the pentose phosphate pathway, which produces a molecule called NADPH. NADPH is the cell’s main defense against oxidative damage. Hemoglobin constantly generates small amounts of reactive oxygen species as a byproduct of carrying oxygen, and without NADPH to neutralize them, those reactive molecules would chew through the cell membrane. This vulnerability is exactly what goes wrong in people who carry a genetic deficiency in a key enzyme of this pathway, called G6PD.8PubMed Central. The pentose phosphate pathway in health and disease
How Old Red Blood Cells Are Cleared
A red blood cell lives for about 120 days. Without a nucleus to direct repairs, it accumulates damage over time: its membrane stiffens, its enzymes degrade, and it loses some of its hemoglobin. The spleen acts as quality control, forcing cells through narrow slits in its tissue. Flexible young cells pass through easily. Rigid old cells get stuck and are consumed by immune cells called macrophages.
The signaling that marks a cell for removal is surprisingly elegant. Young, healthy red blood cells display a protein called CD47 on their surface that sends a “don’t eat me” signal to macrophages. As the cell ages, CD47 undergoes a conformational change that flips that message into an “eat me” signal, and the very same receptor on macrophages that previously left the cell alone now targets it for destruction.9PubMed Central. CD47 in Erythrocyte Ageing and Clearance – the Dutch Point of View After the macrophage swallows the old cell, it salvages the iron from hemoglobin and sends it back into the bloodstream to be recycled into brand-new red blood cells.
When Production Goes Wrong
Anemia, a condition where you do not have enough healthy red blood cells or hemoglobin to carry adequate oxygen, is the most common blood disorder worldwide. The causes are diverse, but three broad categories cover most cases.
- Iron deficiency: Without enough iron, the bone marrow cannot build hemoglobin effectively. Blood loss from heavy menstruation, gastrointestinal bleeding, or a poor diet are the usual culprits. The red blood cells produced are smaller and paler than normal.
- Vitamin B12 or folate deficiency: Both vitamins are needed for DNA synthesis. When either is lacking, red blood cell precursors cannot divide normally and instead grow abnormally large, a condition called megaloblastic anemia.10Blood. The effect of folate analogues and vitamin B12 on provision of thymine nucleotides for DNA synthesis in megaloblastic anemia B12 deficiency is common in older adults whose stomachs no longer absorb it well, while folate deficiency tends to show up in pregnancy or in people with very restricted diets.
- Chronic disease: Inflammation drives up hepcidin, which traps iron inside storage cells and starves the bone marrow. This is why people with long-standing infections, autoimmune conditions, or kidney failure often become anemic even without bleeding or dietary deficiencies.
Sickle Cell Disease and Other Hemoglobin Disorders
Some of the most consequential red blood cell disorders come from mutations in hemoglobin itself. In sickle cell disease, a single amino acid change at the sixth position of hemoglobin’s beta chain causes the protein to polymerize into stiff fibers when oxygen levels drop.11PubMed Central. Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell disease Those fibers distort the red blood cell into a crescent or “sickle” shape, making it rigid and sticky. Sickled cells clog small blood vessels, causing episodes of intense pain, organ damage, and a shortened red blood cell lifespan that leads to chronic anemia.
What makes sickle cell particularly interesting from a biological standpoint is its relationship with malaria. Carrying one copy of the sickle gene (sickle cell trait) confers partial protection against severe malaria, which explains why the mutation persists at high frequencies in populations from malaria-endemic regions. Two copies cause full-blown sickle cell disease. It is one of the clearest examples of a genetic trade-off in human biology.
Thalassemias are another major group of hemoglobin disorders. Rather than producing an abnormal hemoglobin, thalassemias involve reduced production of normal hemoglobin chains. When one chain is underproduced, the other chain accumulates and damages developing red blood cells in the bone marrow. Severe forms require regular transfusions, but milder forms often go undiagnosed and cause only a slight anemia.
When the Membrane Fails
A different category of red blood cell disorder arises when the structural skeleton of the cell is defective. Hereditary spherocytosis is the classic example: mutations in spectrin, ankyrin, band 3, or other scaffold proteins weaken the connection between the membrane and its underlying skeleton. The cell loses bits of membrane over time and rounds up into a sphere instead of maintaining its normal disc shape. Spherical cells cannot squeeze through the spleen’s filtering slits and are destroyed prematurely, causing hemolytic anemia. Research on spectrin mutations has shown that even a single amino acid substitution can disrupt spectrin’s ability to link into the stable networks the membrane depends on, leading to a pronounced drop in the cell’s mechanical stability.12PubMed Central. Red cell shape regulation by band 3-ankyrin-spectrin linkage: implications for clinical severity of bovine hereditary spherocytosis
G6PD deficiency, mentioned earlier, causes a different kind of hemolysis. Under normal conditions, people with this deficiency feel fine. But exposure to certain triggers, including certain drugs, fava beans, and infections, generates a burst of oxidative stress that the cell cannot handle because it lacks enough NADPH. The cell’s membrane gets damaged and breaks open. G6PD deficiency is the most common enzyme deficiency in humans, affecting an estimated 400 million people worldwide, and like sickle cell trait, its prevalence is highest in malaria-endemic regions because it too appears to offer partial protection against the parasite.
Too Many Red Blood Cells
While anemia means too few red blood cells, the opposite problem also exists. Polycythemia vera is a condition where the bone marrow overproduces red blood cells, along with white blood cells and platelets. The blood becomes abnormally thick, raising the risk of blood clots, strokes, and heart attacks. In most cases, the underlying cause is a mutation in the JAK2 gene that locks a growth-signaling pathway into the “on” position, causing marrow cells to multiply without the normal checks.13SDÜ Tıp Fakültesi Dergisi. Polisitemia Vera Olgularında JAK2 V617F Mutasyon Sıklığı ve Laboratuvar Bulguları ile İlişkisi
Not all increases in red blood cell count are harmful or abnormal. Living at high altitude naturally raises your red blood cell mass because the lower oxygen triggers more EPO release. After about four days at around 3,500 meters, 2,3-BPG levels rise enough to measurably shift hemoglobin’s oxygen-releasing behavior, helping tissues extract more oxygen from each passing red blood cell.14PubMed Central. A new approach to haemoglobin oxygen affinity research at high altitude Athletes and endurance competitors have long been aware of these altitude-driven changes, and the synthetic version of EPO became one of the most notorious performance-enhancing drugs in sports precisely because it mimics the same pathway.
Red Blood Cells and Malaria
The malaria parasite has evolved an intricate set of tools to invade red blood cells, and much of what we know about red blood cell surface biology comes from studying this interaction. Different species and strains of the parasite use different entry points. The parasite Plasmodium falciparum, which causes the most severe form of malaria, encodes specific proteins that latch onto receptors on the red blood cell surface.15PubMed Central. Red cell receptors as access points for malaria infection
One well-studied invasion route involves a parasite protein called EBA175, which binds to glycophorin A on the red blood cell surface. This binding does not just provide an anchor; it actually changes the physical properties of the host cell, increasing the tension in the cytoskeleton while loosening the membrane, effectively softening the cell for easier entry.16PubMed Central. Plasmodium falciparum erythrocyte-binding antigen 175 triggers a biophysical change in the red blood cell that facilitates invasion Another invasion mechanism relies on band 3, the same membrane protein critical for the cell’s structure and gas exchange, which can serve as an entry receptor through a pathway that does not depend on the sugar molecules (sialic acids) coating the cell surface.17Blood. A Novel Plasmodium falciparum Microneme Protein Interacts with Host Band 3 during Red Cell Invasion
The fact that the malaria parasite exploits multiple receptors and pathways is part of what makes it so difficult to block. This redundancy also helps explain why several different red blood cell genetic variants, including sickle hemoglobin, G6PD deficiency, thalassemia traits, and even the absence of certain blood group antigens like Duffy, all persist at high rates in malaria zones. Each alters the red blood cell in a way that partially disrupts one or more of the parasite’s invasion or survival strategies.
Blood Types, Transfusions, and the Push for Universal Red Cells
Red blood cells carry surface antigens that define your blood type. Most people know about the ABO and Rh systems, but the full picture is far more complex: there are 47 recognized blood group systems encompassing 366 antigens.18PubMed Central. Engineering the Universal Donor: CRISPR-Mediated Blood Group Antigen Deletion and the Path Toward Truly Universal Red Blood Cells-A Narrative Review For people who receive occasional transfusions, ABO and Rh matching is usually enough. But for patients who need chronic transfusions, such as those with sickle cell disease or thalassemia major, repeated exposure to non-ABO antigens can trigger the immune system to produce antibodies against those foreign proteins. This happens in roughly 20 to 50 percent of chronically transfused patients, making it progressively harder to find compatible blood.
Researchers are now using gene-editing tools to tackle this problem. In laboratory experiments, CRISPR-Cas9 has been used to simultaneously delete ABO, Rh, Kell, Duffy, and MNS antigens from lab-grown red blood cell precursors, moving toward the goal of a truly universal donor cell that would not trigger immune reactions in any recipient. These engineered cells are still far from the clinic, but the approach represents a fundamentally different strategy from the decades-old search for synthetic blood substitutes.
Engineered Alternatives to Donor Blood
The idea of an artificial substitute for red blood cells has been pursued since the mid-twentieth century. The most developed approach involves hemoglobin-based oxygen carriers, which are essentially free hemoglobin molecules modified to stay stable in the bloodstream and release oxygen at useful rates. These products aim to work in emergencies where matched donor blood is unavailable and could be stored far longer than donated red blood cells, which must be refrigerated and used within about six weeks.19PubMed Central. Hemoglobin-Based Oxygen Carriers: Selected Advances and Challenges in the Design of Safe Oxygen Therapeutics
Free hemoglobin outside a red blood cell is not inherently safe, however. Hemoglobin scavenges nitric oxide, a key signaling molecule that keeps blood vessels dilated, and early hemoglobin-based products caused dangerous spikes in blood pressure as a result. Newer designs use chemical cross-linking, polymerization, or encapsulation in synthetic membranes to mitigate these effects, though no product has yet reached routine clinical use. In parallel, researchers are working on growing red blood cells from stem cells in bioreactors, which would produce cells that are functionally identical to natural ones. A small clinical trial in the UK transfused lab-grown red blood cells into human recipients for the first time in 2022, marking an important proof of concept even though mass production remains a daunting manufacturing challenge.
Why Most Mammals Gave Up the Nucleus
Nearly all mammals have red blood cells that lack a nucleus, which is unusual in the animal kingdom. Birds, reptiles, amphibians, and fish all retain nucleated red blood cells. Researchers have compared red blood cell traits across species to understand whether ditching the nucleus gave mammals a measurable advantage. While bird red blood cells tend to be larger in volume, the hemoglobin concentration per cell does not differ meaningfully between birds and mammals once evolutionary relationships are taken into account.20PubMed. Revisiting the question of nucleated versus enucleated erythrocytes in birds and mammals
The leading hypothesis is that losing the nucleus allows mammalian red blood cells to be smaller, more deformable, and more densely packed with hemoglobin. Smaller cells can navigate tighter capillary networks, which may support the higher metabolic rates that mammals require. The nucleus is a bulky object that limits how much a cell can fold and flex. Removing it also means the cell cannot become infected by viruses that need a nucleus to replicate, which may offer a subtle immune advantage. Whatever the full evolutionary story, the result is a cell stripped down to the bare essentials of oxygen delivery, optimized to do one job extraordinarily well for about four months before being recycled and replaced.